- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tesaglitazar
Total 17 results
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United Kingdom, Finland, Norway, Canada, Mexico, Argentina, Brazil, United States
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
AstraZenecaTerminatedType 2 DiabetesItaly, Finland, United Kingdom
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
AstraZenecaTerminatedType 2 DiabetesCzech Republic, France, Poland, Philippines, Estonia, Latvia, Lithuania, Norway, Hungary, Slovakia, Greece, Sweden, Australia, Former Serbia and Montenegro
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, Italy, Korea, Republic of, Russian Federation, South Africa, United Kingdom, Vietnam, Philippines, Malaysia, Estonia, Latvia, Lithuania, Poland, Finland, Canada, Hong Kong, Argentina, Hun... and more
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico